AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9931893
Drug: Postoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiotherapy (50.4 Gy) and 6 cycles of 5‐fluorouracil and medium‐dose folinic acid
Trial: 2838151
Drug: Single-dose dactinomycin
RxNorm normalized name: Dactinomycin
DrugBank: Dactinomycin (DB00970)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose dactinomycin (60 micrograms/kg, later reduced to 45 micrograms/kg)
Trial: 16776894
Drug: Special intervention
RxNorm normalized name: epinephrine / mepivacaine hydrochloride Injectable Solution [Scandonest 2% Special]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Special intervention (individual counseling visit, twelve group sessions, three postcard messages, twelve monthly telephone calls)
Trial: 8751743
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (alpha‐tocopherol) 200 mg daily by mouth for 3 months
Trial: 30052571
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (LGG) supplementation (10 billion colony-forming units daily for 6 months)
Trial: 18684176
Drug: Direct Observed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct Observed Therapy (DOT)
Trial: 18684176
Drug: Self-Administration (SA)
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-Administration (SA)
Trial: 16395298
Drug: Modafinil 400
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 400 mg
Trial: 1792400
Drug: Thiopental 5
RxNorm normalized name: thiopental 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5 mg/kg
Trial: 2058666
Drug: Chloroquine phosphate,
RxNorm normalized name: Chloroquine Phosphate, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine phosphate, 250 mg four times daily for 3 days
Trial: 28560503
Drug: Diet supplemented
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet supplemented with an additional 480 g of fruit and vegetables and 300 ml of fruit juice daily for 12 weeks
Trial: 25317365
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once daily
Trial: 16145317
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (50 microg/day) continuously and transdermal norethisterone (250 microg/day for 14 days of every 28‐day cycle)
Trial: 16145317
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol and norethisterone
Trial: 9695722
Drug: Urodilatin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urodilatin infusion (7.5 to 15 to 30 ng.kg body weight‐1.min‐1)
Trial: 12627187
Drug: Increased folate
RxNorm normalized name: folate
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Increased folate intake through diet and supplement (400 microg folic acid)
Trial: 7941942
Drug: Ibuprofen 40
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 40 mg.kg‐1.d‐1, divided into four equal doses
Trial: 12624551
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (4 mg.kg(‐1) thiopental and 1.5 mg.kg(‐1) succinylcholine)
Trial: 16244520
Drug: Intramuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular electrical stimulation
Trial: 7992066
Drug: Hyperfractionated accelerated
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperfractionated accelerated radiotherapy (2 x 1.6 Gy/d 5 days per week; total dose, 64 to 67.2 Gy) plus simultaneous intravenous carboplatin (60 mg/m2, days 1-5 and 29-33)
Trial: 9457403
Drug: Inhaled IL-2
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled IL-2 therapy (high-dose inhalation)
Trial: 24535888
Drug: Fexinidazole loading
RxNorm normalized name: fexinidazole
DrugBank: Fexinidazole (DB12265)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexinidazole loading dose of 1,800 mg/day for 4 days followed by 1,200 mg/day for 6 days with a normal meal
Trial: 22721971
Drug: IL-2 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-2 therapy
Trial: 7661476
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia and postoperative patient-controlled intravenous narcotic analgesia (GEN)
Trial: 9421122
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with ranitidine 300 mg b.i.d and clarithromycin 750 mg b.i.d, plus placebo (Group A)
Trial: 2746493
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose lorazepam (0.045 mg/kg)
Trial: 19056608
Drug: Hypoglycemic clamp
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypoglycemic clamp (2.8 mmol/l)
Trial: 11437980
Drug: Caloric liquid
RxNorm normalized name: Chloric acid
DrugBank: Chloric acid (DB14150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caloric liquid meal with paracetamol administered orally with nasogastric tube
Trial: 26410620
Drug: dacarbazine 1000
RxNorm normalized name: Dacarbazine
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dacarbazine 1000 mg/m² every 3 weeks
Trial: 17049060
Drug: MMF with
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF with 50% dose reduction of CsA
Trial: 2233278
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17 beta‐estradiol plus 1 mg norethisterone acetate daily for 1 year
Trial: 2233278
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets for 1 year
Trial: 25519029
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) administration
Trial: 8418401
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical treatment alone (medical group; n=233)
Trial: 21443601
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg and ketoconazole 200 mg
Trial: 15504127
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg b.i.d. (single-day oral treatment)
Trial: 1796238
Drug: Quinine 10
RxNorm normalized name: quinine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine 10 mg/kg body weight once daily for 3 days
Trial: 3914180
Drug: Vitamin B-6
RxNorm normalized name: Vitamin B-6 100mg Tablet
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B-6 100 mg daily and Placebo
Trial: 11535961
Drug: Antidepressants or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants or counselling
Trial: 8856392
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance test (OGTT) in obese patients
Trial: 25256660
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg via subcutaneous injection into the abdomen
Trial: 25256660
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg via subcutaneous injection (all sites)
Trial: 450561
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of vitamin E (10 mg/kg/day) to safflower oil
Trial: 24382095
Drug: Early-onset alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early-onset alcohol and drug users (n=122; 67%)
Trial: 6990875
Drug: Inhaled powder
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled powder of fenoterol
Trial: 28807017
Drug: Metronidazole treatment
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole treatment
Trial: 1318845
Drug: Hydrochlorothiazide 25-50
RxNorm normalized name: captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25-50 mg
Trial: 26253567
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of hydrochlorothiazide and amiloride at half doses
Trial: 15608809
Drug: Green Prescription
RxNorm normalized name: acid green 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green Prescription physical activity counselling programme
Trial: 10395859
Drug: 4% gel
RxNorm normalized name: Nicomide-T 4% Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% gel (Conceptrol)
Trial: 17717913
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy with diclofenac sodium, Leflunomide and prednisone
Trial: 11318886
Drug: Isometheptene mucate,
RxNorm normalized name: Isometheptene Mucate, Dichloralphenazone, and Acetaminophen Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isometheptene mucate, dichloralphenazone with acetaminophen
Trial: 12548209
Drug: Gentamicin 1.5
RxNorm normalized name: HYDROCORTISONE ACEPONATE 1.11 mg in 1 mL / MICONAZOLE NITRATE 17.4 mg in 1 mL / GENTAMICIN 1.5 mg in 1 mL AURICULAR (OTIC) SUSPENSION [EASOTIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin 1.5 mg/kg and clindamycin phosphate 900 mg administered every 8 hours
Trial: 8902446
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (37 men with significant antisperm antibodies)
Trial: 31345267
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of durvalumab, olaparib, and cediranib
Trial: 9731851
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1200 mg elemental calcium per day)
Trial: 28476440
Drug: Intravenous rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous rituximab (375 mg/m2)
Trial: 24821885
Drug: Subcutaneous rituximab
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous rituximab (375 mg/m2, 625 mg/m2, or 800 mg/m2)
Trial: 11748103
Drug: L-NMMA infusion
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA infusion in Hyperthyroidism (H)
Trial: 21118280
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg
Trial: 23512415
Drug: Insulin Aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin Aspart (IA)
Trial: 17888133
Drug: Regular Human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular Human Insulin (HI)
Trial: 6137325
Drug: Chlorthalidone, 100
RxNorm normalized name: Chlorthalidone, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone, 100 mg/day
Trial: 11570305
Drug: Research into
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Research into defibrinogenating and neuroprotective agents
Trial: 20206795
Drug: Ticlopidine 250
RxNorm normalized name: ticlopidine 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine 250 mg with Ginkgo biloba extract 80 mg
Trial: 14740127
Drug: Graduated compression
RxNorm normalized name: oxygen
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graduated compression stockings (GCS) in combination with heparin
Trial: 22686415
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (1-g capsule containing at least 900 mg of ethyl esters of n-3 fatty acids daily)
Trial: 6367432
Drug: Cefaclor and
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor and Amoxicillin
Trial: 8551317
Drug: Propofol at
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol at subhypnotic doses
Trial: 21901396
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg daily and 5-azacytidine 75 mg/m2 daily on days 1-4 and 15-18 of a 28-day cycle
Trial: 15951475
Drug: Conventional dipyridamole
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional dipyridamole tablets (two 100 mg tablets + 81 mg aspirin)
Trial: 8273981
Drug: Aspirin 324
RxNorm normalized name: aspirin 324 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 324 mg/d
Trial: 8273981
Drug: Aspirin 1300
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 1300 mg/d
Trial: 22584491
Drug: Mg Pidolate
RxNorm normalized name: Pidolic acid
DrugBank: Pidolic acid (DB03088)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg Pidolate (MgP) 3.0 g/day for 30 days (equivalent to 260 mg of Mg element)
Trial: 1999002
Drug: 250-mg flutamide
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250-mg flutamide tablets three times daily
Trial: 335794
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of thiazide and methyldopa (regimen A)
Trial: 17169543
Drug: Kytta-Salbe f
RxNorm normalized name: F-15599
DrugBank: F-15599 (DB16936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kytta-Salbe f (comfrey root extract ointment)
Trial: 3303813
Drug: Low-dose prostaglandin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prostaglandin F2 alpha (PGF2 alpha)
Trial: 19256728
Drug: Psychiatric Music
RxNorm normalized name: INVESTIGATIONAL DRUGS FOR PSYCHIATRIC DISEASE,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychiatric Music Therapy
Trial: 17580544
Drug: Ultrasound treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound treatment applied on lumbar paravertebral muscle
Trial: 20226302
Drug: Levocetirizine 5
RxNorm normalized name: Levocetirizine 5mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levocetirizine 5 mg, 10 mg, 20 mg
Trial: 16650535
Drug: Diluted epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diluted epinephrine injection alone (n = 53)
Trial: 26811189
Drug: Regional blocks
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional blocks (bilateral CNV2 and CNV3 divisions of the trigeminal nerve) with local anaesthesia containing 1/100,000 epinephrine and 10 ml 0.5% levobupivacaine.
Trial: 3069774
Drug: Intravesically administered
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesically administered Cetiprin (emepronium bromide)
Trial: 21790621
Drug: Restrictive transfusion
RxNorm normalized name: Pinus spp. wood destructive distillate
DrugBank: Pine tar (DB15840)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive transfusion strategy (RBCs if Hb concentration was 70 g/L or less intraoperatively during CPB and 75 g/L or less postoperatively)
Trial: 7661265
Drug: Washout with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Washout with lactated Ringer's solution
Trial: 17019629
Drug: Weekly assessments
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly assessments
Trial: 11276371
Drug: GM-CSF followed
RxNorm normalized name: axatilimab-csfr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF followed by G-CSF
Trial: 23806459
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray (FFNS), 110 μg once daily
Trial: 17049710
Drug: Biological threat
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological threat stimuli (CS+) directed towards participants
Trial: 31596648
Drug: Ria Treatment
RxNorm normalized name: Riax
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ria Treatment Platform (RTP)
Trial: 16409425
Drug: 2-weekly regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-weekly regimen of gemcitabine (1250 mg/qm, day 1) and paclitaxel (120 mg/qm, day 2)
Trial: 18281266
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with 3 MU s.c. of IFNalpha2a plus DTIC 850 mg/m(2) every 4‐8 weeks for 2 years (Arm B)
Trial: 25287554
Drug: Hypnotic analgesia
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic analgesia
Trial: 17028353
Drug: sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sublingual misoprostol
Trial: 17028353
Drug: oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oxytocin infusion after artificial rupture of membranes
Trial: 31765988
Drug: Xelox +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xelox + AZD8931 (20 mg bd with 4/3 schedule)
Trial: 9540877
Drug: Amoxicillin for
RxNorm normalized name: Amoxicillin for Oral Suspension
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin for 2 weeks
Trial: 19300380
Drug: Epidural Steroids
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural Steroids
Trial: 8158539
Drug: Low-dose daily
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose daily TMP-SMX
Trial: 363977
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of clomipramine in a single bedtime dosage
Trial: 9352390
Drug: Test preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test preparation (180 mg diltiazem-HCl)
Trial: 26492924
Drug: Online haemodiafiltration
RxNorm normalized name: FILTER,SUCTION,INLINE #FHBF200S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online haemodiafiltration (HDF) with high delivered convection volume (>23 L per 1.73 m² BSA per session)
Trial: 27482783
Drug: Control implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control implant
Trial: 19212238
Drug: Laser-Lok (LL)
RxNorm normalized name: Lokara
DrugBank: Desonide (DB01260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laser-Lok (LL) implant
Trial: 8889115
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g creatine daily
Trial: 24029539
Drug: Long-term group
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term group therapy (80 weekly, 90 min sessions)
Trial: 2156976
Drug: Veterans Administration
RxNorm normalized name: benzalkonium chloride Topical Foam [Veteran Shield 24]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veterans Administration (VA) Medical Center
Trial: 3086203
Drug: Vasopressin plus
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressin plus sublingual nitroglycerin (0.6 mg every 30 min for 6 hr)
Trial: 22422082
Drug: Ozone nano-bubble
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone nano-bubble water (NBW3) irrigation as an adjunct to mechanical debridement